News

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
Changes are happening around COVID-19 vaccines: Here's what to know
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
What we know about the safety, efficacy of mRNA vaccines amid recent scrutiny
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
FDA advisers debate COVID vaccine recipe amid questions about fall shots
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
Healio14h
FDA tells vaccine makers to expand warning labels on COVID-19 shots
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
FDA Updates COVID-19 Vaccine Regulations—Here’s What to Know
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...
mlive13h
COVID-19 booster eligibility may be changing. Michigan’s uptake was already low
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
US FDA advisers to weigh composition of COVID vaccines for 2025-2026
The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...
FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...